Discontinuation of hypnotics during cognitive behavioural therapy for insomnia.
BACKGROUND
In practical sleep medicine, therapists face the question of whether or not to discontinue the ongoing use of hypnotics in patients, as well as the possible effects of discontinuation. The aim of this study was to evaluate the effects of discontinuing third-generation hypnotics on the results of cognitive-behavioural therapy (CBT) for primary insomnia in patients after long-term abuse.


METHODS
Twenty-eight outpatients were treated by CBT for 8 weeks. The treatment outcome was estimated by means of differences among subjective clinical scales and polysomnography variables assessed before and after the treatment period. The therapeutic effect in a subgroup of 15 patients who had previously received hypnotics and were successively withdrawn during weeks 2-6 was compared to the effect achieved in patients who had not used hypnotics before CBT.


RESULTS
There were no significant differences in baseline subjective and objective sleep characteristics between the hypnotic abusers and non-abusers. According to clinical scales and most polysomnographic measures, CBT was highly effective in both groups of subjects; it produced the greatest changes in total sleep time, REM sleep and sleep efficiency. Unexpectedly, discontinuation of hypnotics, as a factor in the analysis, was followed by an additional improvement of sleep efficiency and wake after sleep onset parameters.


CONCLUSIONS
Our study confirmed the efficacy of CBT in both hypnotic-abusing and non-abusing patients with chronic insomnia. The results of this study suggest that tapered withdrawal of third-generation hypnotics during CBT therapy for chronic insomnia could be associated with improvement rather than worsening of sleep continuity.
Zavesicka
Lucie
L
Prague Psychiatric Center, Ustavni 91, 18103 Prague 8, Czech Republic. zavesicka@pcp.lf3.cuni.cz
Brunovsky
Martin
M
Matousek
Milos
M
Sos
Peter
P
D000328:Adult; D000368:Aged; D015928:Cognitive Behavioral Therapy / Q000379:methods*; D004358:Drug Therapy / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D017286:Polysomnography; D007319:Sleep Initiation and Maintenance Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D012895:Sleep, REM / Q000502:physiology; D028761:Withholding Treatment / Q000706:statistics & numerical data*
D006993:Hypnotics and Sedatives
J Consult Clin Psychol. 2007 Apr;75(2):325-35
17469890
Eur Arch Psychiatry Clin Neurosci. 2001 Jun;251(3):117-23
11697572
Eur J Clin Pharmacol. 1989;36(5):461-6
2666141
Arch Intern Med. 2004 Sep 27;164(17):1888-96
15451764
J Clin Psychiatry. 2007;68 Suppl 5:19-23
17539705
Health Technol Assess. 2004 Feb;8(8):iii-iv, 1-68
14960254
J Int Med Res. 1999;27(6):253-63
10726234
Sleep Med. 2006 Aug;7 Suppl 1:S15-9
16702028
Am J Med. 1996 Feb;100(2):212-6
8629657
BMC Psychiatry. 2004 May 26;4:14
15163350
Psychol Rep. 1974 Jun;34(3):1184-6
4424377
Sleep. 2006 Nov;29(11):1398-414
17162986
J Consult Clin Psychol. 1988 Dec;56(6):893-7
3204199
Am J Psychiatry. 2004 Feb;161(2):332-42
14754783
Behav Res Ther. 2000 Jul;38(7):665-78
10875189
JAMA. 2006 Jun 28;295(24):2851-8
16804151
Br J Med Psychol. 1959;32(1):50-5
13638508
Sleep. 1991 Dec;14(6):540-5
1798888